It has been shown that CD44 interacts with EGFR to promote cell proliferation, migration and induces cisplatin resistance and apoptosis inhibition in HNSCC cells [106], however, these findings should be confirmed in tissues derived from HNSCC patients. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.